Role of FDG-PET/CT in detection of recurrent disease in colorectal cancer

Nuclear Medicine Communications

Volumn 31, Issue 6, 2010, Pages 590-596

  Shamim, Shamim Ahmed ^a   Kumar, Rakesh ^a   Halanaik, Dhanapathi ^a   Shandal, Varun ^a   Reddy, Rama Mohan ^a   Bal, Chandra Shekhar ^a   Malhotra, Arun ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

18F fluorodeoxyglucose positron emission tomography computed tomography; Carcinoembryonic antigen; Colorectal cancer; Recurrence

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RECURRENCE; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; RECURRENT CANCER;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RECURRENCE; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 77951765057     PISSN: 01433636     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNM.0b013e328338a120     Document Type: Article

References (29)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009; 59:225-249.
2. Cohen AM, Minsky BD, Schilsky RL. Cancer of the colon. In: De Vita VT, Hellman S, Rosenberg SA, editors. Cancer: principle and practice of oncology. Philadelphia: Lippincott-Raven; 1997. pp. 1144-1195.
3. Reske SN, Kotzerke J. FDG-PET for clinical use. Eur J Nucl Med 2001; 28:1707-1723.
4. Flamen P, Stroobants S, Van Cutsem E, Dupont P, Bormans G, De Vadder N, et al. Additional value of whole-body positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose in recurrent CRC. J Clin Oncol 1999; 17:894-901.
5. Titu LV, Nicholson AA, Hartley JE, Breen DJ, Monson JR. Routine follow-up by magnetic resonance imaging does not improve detection of resectable local recurrences from CRC. Ann Surg 2006; 243:348-352.
6. Torricelli P, Pecchi A, Luppi G, Romagnoli R. Gadolinium-enhanced MRI with dynamic evaluation in diagnosing the local recurrence of rectal cancer. Abdom Imaging 2003; 28:19-27.
7. Veit P, Kühle C, Beyer T, Kuehl H, Herborn CU, Börsch G, et al. Whole body positron emission tomography/computed tomography (PET/CT) tumour staging with integrated PET/CT colonography: technical feasibility and first experiences in patients with CRC. Gut 2006; 55:68-73.
8. Delbeke D, Vitola JV, Sandler MP, Arildsen RC, Powers TA,Wright JK Jr, et al. Staging recurrent metastatic CRC with PET. J Nucl Med 1997; 38:1196-1201.
9. Ogunbiyi OA, Flanagan FL, Dehdashti F, Siegel BA, Trask DD, Birnbaum EH, et al. Detection of recurrent and metastatic CRC: comparison of positron emission tomography and computed tomography. Ann Surg Oncol 1997; 4:613-620.
10. Ruers TJ, Langenhoff BS, Neeleman N, Jager GJ, Strijk S, Wobbes T, et al. Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study. J Clin Oncol 2002; 20:388-395. (Pubitemid 34072520)
11. Tsunoda Y, Ito M, Fujii H, Kuwano H, Saito N. Preoperative diagnosis of lymph node metastases of CRC by FDG-PET/CT. Jpn J Clin Oncol 2008; 38:347-353.
12. Khatri VP, Chee KG, Petrelli NJ. Modern multimodality approach to hepatic colorectal metastases: solutions and controversies. Surg Oncol 2007; 16:71-83.
13. Inoue M, Ohta M, Iuchi K, Matsumura A, Ideguchi K, Yasumitsu T, et al. Benefits of surgery for patients with pulmonary metastases from CRC. Ann Thorac Surg 2004; 78:238-244.
14. Ito K, Kato T, Tadokoro M, Ishiguchi T, Oshima M, Ishigaki T, et al. Recurrent rectal cancer and scar: differentiation with PET and MR imaging. Radiology 1992; 182:549-552.
15. Kantorova I, Lipska L, Belohlavek O, Visokai V, Truba M, Schneiderová M, et al. Routine F18-FDG PET preoperative staging of CRC: comparison with conventional staging and its impact on treatment decision making. J Nucl Med 2003; 44:1784-1788.
16. Kumar R, Bhargava P, Bozkurt MF, Zhuang H, Potenta S, Alavi A, et al. Positron emission tomography imaging in evaluation of cancer patients. Indian J Cancer 2003; 40:87-100.
17. Kitajima K, Murakami K, Yamasaki E, Domeki Y, Tsubaki M, Sunagawa M, et al. Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent uterine cancer: comparison with PET and enhanced CT. Eur J Nucl Med Mol Imaging 2009; 36:362-372.
18. Fukunaga H, Sekimoto M, Ikeda M, Higuchi I, Yasui M, Seshimo I, et al. Fusion image of positron emission tomography and computed tomography for the diagnosis of local recurrence of rectal cancer. Ann Surg Oncol 2005; 12:561-569 [Epub 2005 May 9]
19. Ziessman HA, Thrall JH, O'Malley JP. Oncology: positron emission tomography. Nuclear medicine: the requisites in radiology. Philadelphia: Elsevier-Mosby; 2006. pp. 302-345.
20. Chen LB, Tong JL, Song HZ, Zhu H, Wang YC. 18F-DG PET/CT in detection of recurrence and metastasis of CRC. World J Gastroenterol 2007; 13:5025-5029.
21. Soyka J, Veit-Haibach P, Strobel K, Breitenstein S, Tschopp A, Mende KA, et al. Staging pathways in recurrent CRC: is contrast-enhanced F18-FDG PET/CT the diagnostic tool of choice? J Nucl Med 2008; 49:354-361.
22. Votrubova J, Belohlavek O, Jaruskova M, Oliverius M, Lohynska R, Trskova K, et al. The role of FDG-PET/CT in the detection of recurrent CRC. Eur J Nucl Med Mol Imaging 2006; 33:779-784.
23. Even-Sapir E, Parag Y, Lerman H, Gutman M, Levine C, Rabau M, et al. Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection. Radiology 2004; 232:815-822.
24. Kim JH, Czernin J, Allen-Auerbach M, Halpern BS, Fueger BJ, Hecht JR, et al. Comparison between F18-FDG PET, in-line PET/CT, and software fusion for restaging of recurrent CRC. J Nucl Med 2005; 46:587-595.
25. Nakamoto Y, Sakamoto S, Okada T. Clinical value of manual fusion of PET and CT images in patients with suspected recurrent CRC. AJR 2007; 188:257-267.
26. Schmidt GP, Baur-Melnyk A, Haug A, Utzschneider S, Becker CR, Tiling R, et al. Whole-body MRI at 1.5 T and 3 T compared with FDG-PET-CT for the detection of tumour recurrence in patients with colorectal cancer. Eur Radiol 2009; 19:1366-1378.
27. Kumar R, Chauhan A, Zhuang H, Chandra P, Alavi A. Clinicopathologic factors associated with false negative FDG-PET in primary breast cancer. Breast Cancer Res Treat 2006; 98:267-274.
28. Fischer BM, Olsen MW, Ley CD, Klausen TL, Mortensen J, Højgaard L, et al. How few cancer cells can be detected by positron emission tomography? A frequent question addressed by an in vitro study. Eur J Nucl Med Mol Imaging 2006; 33:697-702.
29. Das CJ, Makharia G, Kumar R, Chawla M, Goswami P, Malhotra A. PET-CTenteroclysis: a new technique for evaluation of inflammatory diseases of the intestine. Eur J Nucl Med Mol Imaging 2007; 34:2106-2114